247 related articles for article (PubMed ID: 36034780)
1. Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.
Hecker M; Frahm N; Bachmann P; Debus JL; Haker MC; Mashhadiakbar P; Langhorst SE; Baldt J; Streckenbach B; Heidler F; Zettl UK
Front Pharmacol; 2022; 13():946351. PubMed ID: 36034780
[No Abstract] [Full Text] [Related]
2. Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.
Debus JL; Bachmann P; Frahm N; Mashhadiakbar P; Langhorst SE; Streckenbach B; Baldt J; Heidler F; Hecker M; Zettl UK
Ther Adv Chronic Dis; 2022; 13():20406223221108391. PubMed ID: 35959503
[TBL] [Abstract][Full Text] [Related]
3. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
Amkreutz J; Koch A; Buendgens L; Trautwein C; Eisert A
J Clin Pharm Ther; 2017 Jun; 42(3):276-285. PubMed ID: 28224645
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy.
Bachmann P; Frahm N; Debus JL; Mashhadiakbar P; Langhorst SE; Streckenbach B; Baldt J; Heidler F; Hecker M; Zettl UK
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335968
[TBL] [Abstract][Full Text] [Related]
5. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions in ICU patients: a retrospective study.
Ali I; Bazzar A; Hussein N; Sahhar E
Drug Metab Pers Ther; 2020 Jul; 35(3):. PubMed ID: 32681774
[TBL] [Abstract][Full Text] [Related]
7. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
Nusair MB; Al-Azzam SI; Arabyat RM; Amawi HA; Alzoubi KH; Rabah AA
Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study.
Wondm SA; Tamene FB; Gubae K; Dagnew SB; Worku AA; Belachew EA
BMJ Open; 2023 Dec; 13(12):e077863. PubMed ID: 38070913
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
[TBL] [Abstract][Full Text] [Related]
11. Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.
Schneider KL; Kastenmüller K; Weckbecker K; Bleckwenn M; Böhme M; Stingl JC
Drugs Aging; 2018 Jun; 35(6):559-568. PubMed ID: 29737468
[TBL] [Abstract][Full Text] [Related]
12. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients.
Murtaza G; Khan MY; Azhar S; Khan SA; Khan TM
Saudi Pharm J; 2016 Mar; 24(2):220-5. PubMed ID: 27013915
[TBL] [Abstract][Full Text] [Related]
13. Drug-drug interactions in the intensive care unit: Do they really matter?
Vanham D; Spinewine A; Hantson P; Wittebole X; Wouters D; Sneyers B
J Crit Care; 2017 Apr; 38():97-103. PubMed ID: 27883969
[TBL] [Abstract][Full Text] [Related]
14. Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey.
Grizzle AJ; Horn J; Collins C; Schneider J; Malone DC; Stottlemyer B; Boyce RD
J Med Internet Res; 2019 Jan; 21(1):e11182. PubMed ID: 30609981
[TBL] [Abstract][Full Text] [Related]
15. Analysis of potential drug-drug interactions in medical intensive care unit patients.
Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
[TBL] [Abstract][Full Text] [Related]
16. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety.
Noor S; Ismail M; Khan F
Front Pharmacol; 2019; 10():1032. PubMed ID: 31607905
[No Abstract] [Full Text] [Related]
17. Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis.
Dornquast C; Dombrowski M; Zabel M; Willich SN; Reinhold T
BMC Health Serv Res; 2020 Mar; 20(1):271. PubMed ID: 32234046
[TBL] [Abstract][Full Text] [Related]
18. Potentially Harmful Drug-Drug Interactions and Their Associated Factors Among Hospitalized Cardiac Patients: A Cross-Sectional Study.
Kalash A; Abdelrahman A; Al-Zakwani I; Al Suleimani Y
Drugs Real World Outcomes; 2023 Sep; 10(3):371-381. PubMed ID: 37178272
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
[TBL] [Abstract][Full Text] [Related]
20. Potential drug-drug interactions in outpatients with depression of a psychiatry department.
Chen Y; Ding L
Saudi Pharm J; 2023 Feb; 31(2):207-213. PubMed ID: 36942274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
